Exchange transfusion for severe malaria: Evidence base and literature review

Clinical Infectious Diseases

Volumn 57, Issue 7, 2013, Pages 923-928

  Tan, Kathrine R ^a   Wiegand, Ryan E ^a   Arguin, Paul M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Exchange transfusion; Malaria treatment; Severe malaria

Indexed keywords

ARTEMISININ DERIVATIVE;

ADULT RESPIRATORY DISTRESS SYNDROME; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; EXCHANGE BLOOD TRANSFUSION; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOTENSION; MALARIA; NONHUMAN; PARASITE CLEARANCE; PRIORITY JOURNAL; REVIEW; SURVIVAL; TREATMENT OUTCOME;

EXCHANGE TRANSFUSION; MALARIA TREATMENT; SEVERE MALARIA;

ADULT; CASE-CONTROL STUDIES; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; RETROSPECTIVE STUDIES;

EID: 84884393816     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit429     Document Type: Review

References (32)

1. Gyr K, Speck B, Ritz R, Cornu P, Buckner CD. Cerebral tropical malaria with blackwater fever. A current diagnostic and therapeutic problem [in German]. Schweiz MedWochenschr 1974; 104:1628-30.
2. World Health Organization, Communicable Diseases Cluster. Severe falciparum malaria. Trans R Soc TropMed Hyg 2000; 94(suppl 1):S1-90.
3. Clark IA, Budd AC, Alleva LM, Cowden WB. Human malarial disease: a consequence of inflammatory cytokine release. Malar J 2006; 5:85.
4. Chuncharunee S, Jootar JS, Leelasiri A, et al. Levels of serum tumor necrosis factor alpha in relation to clinical involvement and treatment among Thai adults with Plasmodium falciparum malaria. J Med Assoc Thai 1997; 80(suppl 1):S72-5.
5. Valbonesi M, Bruni R. Clinical application of therapeutic erythrocytapheresis (TEA). Transfus Sci 2000; 22:183-94.
6. Hien TT, White NJ. Qinghaosu. Lancet 1993; 341:603-8.
7. Phillips P, Nantel S, Benny WB. Exchange transfusion as an adjunct to the treatment of severe falciparum malaria: case report and review. Rev Infect Dis 1990; 12:1100-8.
8. Karbwang J, Na-Bangchang K, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria. Bull World Health Organ 1994; 72:233-8.
9. Miller KD, Greenberg AE, Campbell CC. Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med 1989; 321:65-70.
10. van Genderen PJ, Hesselink DA, Bezemer JM, Wismans PJ, Overbosch D. Efficacy and safety of exchange transfusion as an adjunct therapy for severe Plasmodium falciparum malaria in nonimmune travelers: a 10-year single-center experience with a standardized treatment protocol. Transfusion 2010; 50:787-94.
11. Riddle MS, Jackson JL, Sanders JW, Blazes DL. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a metaanalysis. Clin Infect Dis 2002; 34:1192-8.
12. Griffith KS, Lewis LS, Mali S, Parise ME. Treatment of malaria in the United States: a systematic review. JAMA 2007; 297:2264-77.
13. Mali S, Kachur SP, Arguin PM, et al. Malaria surveillance - United States, 2010. MMWR Surveill Summ 2012; 61:1-17.
14. Centers for Disease Control and Prevention. Guidelines for treatment of malaria in the United States. Available at: http://www.cdc.gov/malaria/ resources/pdf/treatmenttable.pdf. Accessed 13 May 2013.
15. Hintze J. PASS 11 Available at: http://ncss.wpengine.netdna-cdn.com/wp- content/uploads/2012/09/PASS11QuickStart.pdf. Accessed 1 October 2012.
16. Saddler M. Treatment of severe malaria by exchange transfusion. N Engl J Med 1990; 322:58-9.
17. Auer-Hackenberg L, Staudinger T, Bojic A, et al. Automated red blood cell exchange as an adjunctive treatment for severe Plasmodium falciparum malaria at the Vienna General Hospital in Austria: a retrospective cohort study. Malar J 2012; 11:158.
18. Kreeftmeijer-Vegter AR, Melo Mde M, de Vries PJ, Koelewijn R, van Hellemond JJ, van Genderen PJ. Manual blood exchange transfusion does not significantly contribute to parasite clearance in artesunatetreated individuals with imported severe Plasmodium falciparum malaria. Malar J 2013; 12:115.
19. Szczepiorkowski ZM, Bandarenko N, Kim HC, et al. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2007; 22:106-75.
20. Bellmann R, Sturm W, Pechlaner C, et al. Imported malaria: six cases of severe Plasmodium falciparum infection in Innsbruck, Austria, within a period of five weeks (February/March 1999). Wien Klin Wochenschr 2000; 112:453-8.
21. Molla S, de La Rubia J, Arriaga F, Fernandez MJ, Carpio N, Marty ML. Role of exchange transfusion in patients with severe falciparum malaria: report of six cases. Haematologica 2001; 86:208-9.
22. Moorkens GH, Zachée PB, Coolen LJ, et al. Exchange transfusion for fulminant Plasmodium falciparum infection. Int J Artif Organs 1991; 14:122-3.
23. McCaslin RI, Pikis A, Rodriguez WJ. Pediatric Plasmodium falciparium malaria: a ten-year experience from Washington, DC. Pediatr Infect Dis J 1994; 13:709-15.
24. Mirete Ferrer C, Masia Canuto M, Navarro Ruiz A, Gutierrez Rodero F. Fatal cerebral malaria caused by Plasmodium falciparum after treatment with exchange transfusion [in Spanish]. Med Clin (Barc) 2000; 115:38.
25. Looareesuwan S, Phillips RE, Karbwang J, White NJ, Flegg PJ, Warrell DA. Plasmodium falciparum hyperparasitaemia: use of exchange transfusion in seven patients and a review of the literature. Q J Med 1990; 75:471-81.
26. Norda R, Stegmayr BG Swedish Apheresis Group. Therapeutic apheresis in Sweden: update of epidemiology and adverse events. Transfus Apher Sci 2003; 29:159-66.
27. Boga C, Kozanoglu I, Ozdogu H, Ozyurek E. Plasma exchange in critically ill patients with sickle cell disease. Transfus Apher Sci 2007; 37:17-22.
28. McLeod BC, Sniecinski I, Ciavarella D, et al. Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion 1999; 39:282-8.
29. World Health Organization. Guidelines for the treatment of malaria. Geneva, Switzerland: WHO, 2011.
30. Dondorp A, Nosten F, Stepniewska K, Day N, White N; South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) Group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005; 366:717-25.
31. Harris P, Price S, Senthuran S, Cochupanachimootil J, Norton R. Automated erythrocytapheresis for severe falciparum malaria. Intern Med J 2011; 41(1a):60-3.
32. Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361:455-67.